Royalty Pharma plcRPRXNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank50
3Y CAGR+2.5%
5Y CAGR+4.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+2.5%/yr
vs -7.3%/yr prior
5Y CAGR
+4.7%/yr
Consistent
Acceleration
+9.8pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.46 | +9.2% |
| 2024 | 0.42 | +11.5% |
| 2023 | 0.37 | -11.5% |
| 2022 | 0.42 | +4.5% |
| 2021 | 0.41 | +11.6% |
| 2020 | 0.36 | -27.5% |
| 2019 | 0.50 | -12.6% |
| 2018 | 0.57 | -4.1% |
| 2017 | 0.60 | +6.3% |
| 2016 | 0.56 | - |